With new guidance, FDA moves toward uniform postmarketing reporting

With new guidance, FDA moves toward uniform postmarketing reporting

Source: 
RAPS.org
snippet: 

A new draft guidance related to postmarketing requirements and commitments is available from the US Food and Drug Administration (FDA). The document details how drug and biologics marketers will use two forms for online submission of annual status report and other required postmarketing information.